Characterization of two populations of human coronary artery endothelial cells

被引:11
作者
Wu, HK
Yao, QZ
Lumsden, A
Chen, CY
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Vasc Surg & Endovasc Therapy, Mol Surg Res Ctr, Houston, TX 77030 USA
[2] Methodist Hosp, Houston, TX 77030 USA
关键词
endothelial cells; human coronary artery; flow cytometry; TNF-alpha; adhesion molecules; gene expression; chemokine receptors; eNOS;
D O I
10.1016/j.jss.2004.01.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Heterogeneity of endothelial cells may affect angiogenesis, vascular healing, and cardiovascular disease formation. The objective of this study was to identify and characterize populations of human coronary artery endothelial cells (HCAECs), their gene expression levels, and response to TNF-alpha stimulation. Materials and methods. Commercial HCAECs were cultured with EGM-2 complete medium. Cell population was determined by flow cytometry analysis based on size-scatter distribution. Gene expression for each population with or without TNF-alpha (1 ng/ml) stimulation for 16 h was also studied by flow cytometry analysis with proper gating and fluorescence labeling of antibodies. Results. Two distinguished populations, HCAEC-I (small) and HCAEC-II (large), were identified through all passages (from 2 to 10) during cultures. Both HCAEC-I and HCAEC-II showed more than 90% positive staining for both von Willebrand factor and CD31 and were negative for CD34 and CD4 (less than 2%). HCAEC-I had substantially higher expression of cadherin-5 (71.91% versus 51.07%) than HCAEC-II. HCAEC-I also expressed much higher levels of vascular endothelial growth factor receptor-2 (VEGF-R2) (17.35% versus 0.77%), endothelial nitric oxide synthase (eNOS) (44.64% versus 2.54%), VCAM-1 (6.08% versus 1.18%), E-selectin (18.68% versus 1.42%), CXCR4 (61.05% versus 7.98%), and CCR5 (48.66% versus 1.97%) than HCAEC-II. HCAEC-II, however, had substantially higher expression of P1H12 (93.07% versus 58.73%) and ICAM-1 (94.37% versus 58.62%) than HCAEC-I. Following TNF-alpha stimulation, both populations substantially increased the expression of ICAM-1, VCAM-1, and E-selectin. HCAEC-I, however, had much higher expressions of VEGFR-2, eNOS, CXCR4, and CCR-5 than RACEC-II after TNF-alpha stimulation. Conclusions. These data demonstrate that commercial HCAECs have two distinguished populations with different gene expression patterns and different responses following TNF-alpha stimulation. This study indicates that the heterogeneity of HCAECs may have biologic or pathologic significances in coronary arteries. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 33 条
  • [1] HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE
    ADES, EW
    CANDAL, FJ
    SWERLICK, RA
    GEORGE, VG
    SUMMERS, S
    BOSSE, DC
    LAWLEY, TJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) : 683 - 690
  • [2] Targets for pharmacological intervention of endothelial hyperpermeability and barrier function
    Amerongen, GPV
    van Hinsbergh, VWM
    [J]. VASCULAR PHARMACOLOGY, 2002, 39 (4-5) : 257 - 272
  • [3] Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro
    Amerongen, GPV
    Koolwijk, P
    Versteilen, A
    van Hinsbergh, VWM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) : 211 - 217
  • [4] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [5] Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics
    Barton M.
    [J]. Current Hypertension Reports, 2000, 2 (1) : 84 - 91
  • [6] Role of aldose reductase in TNF-α-induced apoptosis of vascular endothelial cells
    Chandra, D
    Ramana, KV
    Friedrich, B
    Srivastava, S
    Bhatnagar, A
    Srivastava, SK
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 143 : 605 - 612
  • [7] Cines DB, 1998, BLOOD, V91, P3527
  • [8] CROSBY JR, 1997, SCIENCE, V275, P964
  • [9] de Boer AG, 1999, EUR J PHARM SCI, V8, P1
  • [10] DODGERS GM, 1998, FASBE J, V2, P116